Join
Live feed
·
PRReleasevia Quantisnow
Elanco Animal Health Incorporated logo

Elanco Announces FDA Approval and Launch of Zenrelia™ (ilunocitinib tablets), Offering An Effective, Safe Solution in Canine Dermatology

ByQuantisnow·Wall Street's wire, on your screen.
ELAN· Elanco Animal Health Incorporated
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ELAN (Elanco Animal Health Incorporated) and more on Quantisnow.